Hepatology

Demo organization for demonstration purposes only – fictional example, not a real pharmacy group. A network of three owner-managed pharmacies in the Rhine-Neckar region, focused on counselling and prevention for liver, heart and metabolic health: blood pressure checks, medication counselling, nutrition and exercise tips, and guidance on early detection. Brand-neutral information without product promotion. This example shows how a regional pharmacy network can be presented on Liver & Heart.

Demo organization for demonstration purposes only – fictional example, not a real company. Aurelis Pharma (Demo) shows how a pharmaceutical company can be presented on Liver & Heart: focused on research by disease area, collaboration with patient organizations and brand-neutral education, without product or active-ingredient promotion. We research how to detect chronic diseases earlier and support patients better, and we see health as the interplay of liver, heart and metabolism. Sponsorship is clearly labelled and has no influence on editorial content.

Uniklinik RWTH Aachen is a university hospital in Aachen, Germany. At its Department of Gastroenterology, Metabolic Diseases and Medical Intensive Care (Medical Clinic III), a research group studies metabolic liver disease using multi-omics data and artificial intelligence.

Queen Mary University of London (QMUL) is a university in London, United Kingdom. At its Blizard Institute, part of the Faculty of Medicine and Dentistry, an MRC-funded research group studies non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH).

Odense University Hospital (OUH) and the University of Southern Denmark (SDU) jointly host FLASH – Centre for Liver Research, a research centre in Odense, Denmark specialising in liver fibrosis and alcohol-related and non-alcoholic liver disease.

Boehringer Ingelheim is a German family-owned pharmaceutical company founded in 1885, headquartered in Ingelheim am Rhein. It develops medicines in areas including respiratory, metabolic, immunology, oncology and CNS diseases. In liver disease, Boehringer Ingelheim runs its own clinical trials in MASH (metabolic dysfunction-associated steatohepatitis).

Demo organization for demonstration purposes – fictional example, not a real organization. Hospitals and outpatient centers focused on liver, heart and metabolic health in the Rhine-Main region. This example shows how an organization with multiple locations is presented on Liver & Heart.

Vienna General Hospital (AKH Wien) is the university hospital of the Medical University of Vienna and one of the largest hospitals in Europe, with numerous departments including the Division of Gastroenterology and Hepatology (Department of Internal Medicine III).

LKH University Hospital Graz (Medical University of Graz) is the largest hospital in Styria and a university hospital with numerous departments, including the Division of Gastroenterology and Hepatology.

Knappschaftsklinikum Saar GmbH operates two hospital sites in Saarland: the Puttlingen site (Department of Internal Medicine with focus on gastroenterology, hepatology, endocrinology and diabetology, Chief Physician Prof. Dr. med. Vincent Zimmer) and the Sulzbach site (Department of Gastroenterology with the Gastrointestinal Center Saar, Chief Physician Dr. med. Patrizio Merloni). Together the two sites comprise numerous departments ranging from general and visceral surgery to cardiology and radiology.

Echosens is a French medical technology company and the manufacturer of FibroScan®, the reference non-invasive device for assessing liver stiffness (fibrosis) and fat content (steatosis) using Vibration Controlled Transient Elastography (VCTE®). FibroScan is used in over 127 countries. The company is headquartered in Paris, France.

Deutsche Leberhilfe e.V. is a non-profit patient organization founded in Cologne in 1987, supporting people with liver disease and their families through counseling, education, and self-help networking across Germany.